Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis

Yale Journal of Biology and Medicine

Volumn 78, Issue 1, 2005, Pages 25-36

  Alenzi, Faris Q ^a   Al Ghamdi, Saleh M ^b   Tamimi, Waleed G ^b   Al Sebiany, Abdulaziz M ^a   El Nashar, Iman M ^a   El Tounsi, Iman ^c   Bamaga, Mohammad S ^d   Al Enazi, Maher M ^e   Al Amri, Ali S ^a   Al Sheikh, Iman H ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c MENOUFIA UNIVERSITY   (Egypt)

^d Military Forces Hospital   (Saudi Arabia)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FAS ANTIGEN; FAS LIGAND; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; METABOLISM; MYELOPOIESIS; PHYSIOLOGY;

ANTIGENS, CD34; ANTIGENS, CD95; APOPTOSIS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; FAS LIGAND PROTEIN; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; HUMANS; MEMBRANE GLYCOPROTEINS; MYELOPOIESIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 33646464595     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
2. Gruss HJ and Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. 1995;85:3378-404.
3. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, and Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331-67.
4. Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science, 1998;281:1305-9.
5. Krammer PH. CD95's deadly mission in the immune system. Nature 2000;407:789-95.
6. Nagata S and Golstein P. The Fas death factor. Science 1995;267:1449-56.
7. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, and Moller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-27.
8. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, and Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995;86:883-9.
9. Suda T, Takahashi T, Golstein P, and Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
10. Green DR and Ferguson TA. The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2001;2:917-24.
11. Boldin MP, Goncharov TM, Goltsev YV, and Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor induced cell death. Cell 1996;85:803-15.
12. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, and Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-27.
13. Yonehara S, Ishii A, and Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-56.
14. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, and Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-5.
15. - fetal liver cells. Exp Hematol 1999;27:1428-39.
16. +CD38-hematopoietic progenitor cells by suppressing apoptosis. Exp Hematol 1999;27:1451-9.
17. Alenzi FQB, Marley SB, Chandrashekran A, Warrens A, Goldman JM, and Gordon MY. Regulation of hemopoietic progenitor cell number by the Fas/FasL apoptotic mechanism. Exp Hematol 2002;30:1428-35.
18. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, Riccioni R, Felli N, Samoggia P, and Peschle C. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999;93:796-803.
19. Traver D, Akashi K, and Weissman IL, Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 1998;9:47-57.
20. Gordon MY and Blackett NM. Routes to repopulation a unification of the stochastic model and separation of stem cell subpopulations. Leukemia 1994;8:1068-73.
21. Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 1992;20:391-4.
22. Maciejewski J, Selleri C, Anderson S, and Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995;85:3183-90.
23. Anthony RS, Mckelvie ND, Craig JI, Parker AC. Fas antigen (CD95) expression in peripheral blood progenitor cells from patients with leukemia and lymphoma. Leuk Lymphoma 1998;30:449-58.
24. Nagafuji K, Takenaka K, Shibuya T, Harada M, and Niho Y. Fas antigen (CD95) and hematopoietic progenitor cells. Leuk Lymphoma 1996;24:43-56.
25. Selleri C, Sato T, Del Vecchio L, Luciano L, Barrett AJ, Rotoli B, Young NS, and Maciejewski JP. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood 1997;89:957-64.
26. De Maria R, Zeuner A, Eramao A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 1999;401:489-93.
27. Enari M, Hug H, and Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995;375:78-81.
28. Janicke RU, Walker PA, Lin XY, and Porter AG. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996;15:6969-78.
29. Fattman CL, Delach SM, Dou QP, and Johnson DE. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene 2001;20:2918-26.
30. Lewis JL, Nguyen D, Wen B, et al. Contact-mediated inhibition of human haematopoietic progenitor cells resulting from homotypic CD34-CD34 cell adhesion downregulates proteins of the pRb pathway [abstract]. Blood 2001;298:84.
31. Bae SS, Choi JH, Oh YS, Perry DK, Ryu SH, and Suh PG. Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett 2001;491:16-20.
32. Katsuda K, Kataoka M, Uno F, Murakami T, Kondo T, Roth JA, Tanaka N, and Fujiwara T. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene 2000;21:2108-13.
33. Steinman RA and Johnson DE. p21WAF1 prevents down-modulation of the apoptotic inhibitor protein c-IAP1 and inhibits leukemic apoptosis. Mol Med 2000;6:736-49.
34. Lewis JL, Chinswangwatanakul W, Zheng B, Marley SB, Nguyen DX, Cross NC, Banerji L, Glassford J, Thomas NS, Goldman JM, Lam EW, and Gordon MY. The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. Blood 2001;97:2604-10.
35. + accumulation. Proc Natl Acad Sci USA 1995;92:9328-32.
36. Beg AA and Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-4.
37. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, and Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF?B control. Proc Natl Acad Sci USA 1997;94:10057-62.
38. Ravi R, Bedi A, Fuchs EJ, Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res 1998;58:882-6.
39. Kim PK, Wang Y, Gambotto A, Kim YM, Weller R, Zuckerbraun BS, Hua Y, Watkins SC, and Billiar TR. Hepatocyte Fas-associating death domain protein/mediator of receptor-induced toxicity (FADD/MORT1) levels increase in response to pro-apoptotic stimuli. J Biol Chem 2002;277:38855-62.